Teva Pharmaceutical Industries L (NYSE: TEVA) stock enjoyed a major increase of 26.5% on 12/17/24. The shares closed at $20.88. Moreover, trading volume in this advance was exceptionally high at 713% of normal. The stock has been strong relative to the market over the last nine months and has risen 18.6% during the last week.
Current PriceTarget Research Rating
Teva Pharmaceutical Industries L has a current Value Trend Rating of B (Positive). The Value Trend Rating reflects consistent signals from PTR’s two proprietary measures of a stock’s attractiveness. Teva Pharmaceutical Industries L has a slightly positive Appreciation Score of 69 and a good Power Rating of 76, and the Positive Value Trend Rating results.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of B. This review will be completed in the next several days.
Be the first to comment